Agilent technologies openlab

Ended Awarded Last action

Contract number
HHSF223201710261G
Awardee
Awarding agency
Obligated
$115,308

Award facts

Opportunity
Contract value 100% obligated
$115,307.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Marshallton, DE 19808, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 · Agilent technologies openlab - the purpose of this modification is to DE-obligate funds, cancel non-funded items 5, and close out the contract. -$5,076
Exercise an Option P00004 $17,858
Other Administrative Action P00003 $0
Exercise an Option P00002 $17,858
Exercise an Option 1 $17,858
Original award $66,810

About this award

This federal contract award is for $115,307.67 and was issued by the Food and Drug Administration (FDA) to Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract, which has no set-aside designation, is for Agilent's OpenLAB software and scientific equipment and services under the GSA Schedule 66 - Scientific Equipment and Services contract vehicle. Agilent has provided a wide range of analytical instruments, such as liquid chromatography mass spectrometers, gas chromatography mass spectrometers, and inductively coupled plasma mass spectrometers, to support research at various federal agencies including the NIH, CDC, and EPA. The contract has an ultimate completion date of March 31, 2022. Agilent Technologies, Inc., the parent company of the awardee, also holds two active IDIQ contract vehicles, one with the Department of Veterans Affairs for hematoxylin and eosin slide staining systems and another with the Bureau of Alcohol, Tobacco, Firearms and Explosives for gas chromatography mass spectrometry equipment and services.

Quick answers

Who was awarded contract HHSF223201710261G?

HHSF223201710261G was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on August 7, 2017.

How much is contract HHSF223201710261G worth?

The government has obligated $115,308 on HHSF223201710261G.

Is contract HHSF223201710261G an order under another contract?

Yes. HHSF223201710261G is a delivery order under GS07F0564X, a federal supply schedule, on Scientific Equipment and Services (FSS-66).

Was contract HHSF223201710261G competed?

The extent of competition for HHSF223201710261G was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award